Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Petrini

Showing results (71-80 of 254) with videos related to

Pageof 26
Sort By:
Leukemia Research|July 20, 2002
Bone and bone marrow interactions: hematological activity of osteoblastic growth peptide (OGP)-derived carboxy-terminal pentapeptide. II. Action on human hematopoietic stem cellsRita Fazzi, Sara Galimberti, Rossana Testi, et al.
The Journal of Infectious Diseases|January 16, 2008
5-HT2a inhibitors for progressive multifocal leukoencephalopathy: old drugs for an old diseaseDaniele Focosi, Richard Eric Kast, Fabrizio Maggi, et al.
American Journal of Hematology|August 19, 2011
High-dose (40,000 IU twice/week) alpha recombinant human erythropoietin as single agent in low/intermediate risk myelodysplastic syndromes: a retrospective investigation on 133 patients treated in a single institutionAntonio Azzarà, Giovanni Carulli, Sara Galimberti, et al.
Hematology Reports|January 16, 2018
PRDI-BF1 and PRDI-BF1P isoform expressions correlate with disease status in multiple myeloma patientsGabriele Buda, Francesca Guerrini, Sara Galimberti, et al.
British Journal of Haematology|July 16, 2010
CD23 expression in plasma cell leukaemiaGabriele Buda, Giovanni Carulli, Enrico Orciuolo, et al.
Leukemia Research|August 19, 2007
CD45 expression in low-grade B-cell non-Hodgkin's lymphomasGiovanni Carulli, Elisa Cannizzo, Alessandra Zucca, et al.
Annals of Hematology|June 2, 2007
Stable low IgG levels in relapsed non-Hodgkin's lymphomasGabriele Buda, Sara Galimberti, Enrico Orciuolo, et al.
European Journal of Haematology|November 4, 2004
Rituximab as treatment for minimal residual disease in hairy cell leukaemiaGiulia Cervetti, Sara Galimberti, Francesca Andreazzoli, et al.
Journal of Clinical and Experimental Hematopathology : JCEH|October 23, 2015
Combination of CD157 and FLAER to Detect Peripheral Blood Eosinophils by Multiparameter Flow CytometryGiovanni Carulli, Alessandra Marini, Paola Sammuri, et al.
The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry|May 19, 2010
Progressive multifocal leukoencephalopathy: what's new?Daniele Focosi, Tuccori Marco, Richard Eric Kast, et al.
Pageof 26

Showing results (71-80 of 254) with videos related to

Sort By:
Pageof 26
Leukemia Research|July 20, 2002
Bone and bone marrow interactions: hematological activity of osteoblastic growth peptide (OGP)-derived carboxy-terminal pentapeptide. II. Action on human hematopoietic stem cellsRita Fazzi, Sara Galimberti, Rossana Testi, et al.
The Journal of Infectious Diseases|January 16, 2008
5-HT2a inhibitors for progressive multifocal leukoencephalopathy: old drugs for an old diseaseDaniele Focosi, Richard Eric Kast, Fabrizio Maggi, et al.
American Journal of Hematology|August 19, 2011
High-dose (40,000 IU twice/week) alpha recombinant human erythropoietin as single agent in low/intermediate risk myelodysplastic syndromes: a retrospective investigation on 133 patients treated in a single institutionAntonio Azzarà, Giovanni Carulli, Sara Galimberti, et al.
Hematology Reports|January 16, 2018
PRDI-BF1 and PRDI-BF1P isoform expressions correlate with disease status in multiple myeloma patientsGabriele Buda, Francesca Guerrini, Sara Galimberti, et al.
British Journal of Haematology|July 16, 2010
CD23 expression in plasma cell leukaemiaGabriele Buda, Giovanni Carulli, Enrico Orciuolo, et al.
Leukemia Research|August 19, 2007
CD45 expression in low-grade B-cell non-Hodgkin's lymphomasGiovanni Carulli, Elisa Cannizzo, Alessandra Zucca, et al.
Annals of Hematology|June 2, 2007
Stable low IgG levels in relapsed non-Hodgkin's lymphomasGabriele Buda, Sara Galimberti, Enrico Orciuolo, et al.
European Journal of Haematology|November 4, 2004
Rituximab as treatment for minimal residual disease in hairy cell leukaemiaGiulia Cervetti, Sara Galimberti, Francesca Andreazzoli, et al.
Journal of Clinical and Experimental Hematopathology : JCEH|October 23, 2015
Combination of CD157 and FLAER to Detect Peripheral Blood Eosinophils by Multiparameter Flow CytometryGiovanni Carulli, Alessandra Marini, Paola Sammuri, et al.
The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry|May 19, 2010
Progressive multifocal leukoencephalopathy: what's new?Daniele Focosi, Tuccori Marco, Richard Eric Kast, et al.
Pageof 26